BridgeBio Pharma, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2021 to Q4 2024
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
BridgeBio Pharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2021 to Q4 2024.
- BridgeBio Pharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2024 was 186M shares, a 14.3% increase year-over-year.
- BridgeBio Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 186M shares, a 14.3% increase from 2023.
- BridgeBio Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 163M shares, a 10.4% increase from 2022.
- BridgeBio Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 147M shares, a 2.16% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)